Clptm1l promotes growth and enhances aneuploidy in pancreatic cancer cells

Cancer Research

Volumn 74, Issue 10, 2014, Pages 2785-2795

  Jia, Jinping ^a   Bosley, Allen D ^f   Thompson, Abbey ^a   Hoskins, Jason W ^a   Cheuk, Adam ^b   Collins, Irene ^a   Parikh, Hemang ^a   Xiao, Zhen ^f   Ylaya, Kris ^c   Dzyadyk, Marta ^a   Cozen, Wendy ⁱ   Hernandez, Brenda Y ^j   Lynch, Charles F ^k   Loncarek, Jadranka ^g   Altekruse, Sean F ^d   Zhang, Lizhi ^l   Westlake, Christopher J ^h   Factor, Valentina M ^e   Thorgeirsson, Snorri ^e   Bamlet, William R ^l   Hewitt, Stephen M ^c   Petersen, Gloria M ^l   Andresson, Thorkell ^f   Amundadottir, Laufey T ^a   more..

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Pediatric Oncology Branch   (United States)

^c Laboratory of Pathology   (United States)

^d Cancer Contr and Population Science   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^g Laboratory of Protein Dynamics and Signaling   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^k UNIVERSITY OF IOWA   (United States)

^l MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN II;

ANEUPLOIDY; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SHAPE; CENTROSOME; CLPTM1L GENE; CONTROLLED STUDY; CYTOKINESIS; CYTOPLASM; EMBRYO; ENDOPLASMIC RETICULUM; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TUMOR GENE; TUMOR GROWTH; TUMOR PROMOTION;

ANEUPLOIDY; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FEMALE; HEK293 CELLS; HETEROGRAFTS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, NUDE; MYOSIN TYPE II; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; SUBCELLULAR FRACTIONS;

EID: 84901253013     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3176     Document Type: Article

References (48)

1. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010;42:978-84.
2. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011;43:1210-4.
3. Shete S, Hosking FJ, Robertson LB,Dobbins SE, Sanson M, Malmer B, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009;41:899-904.
4. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008;40:1407-9.
5. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-6.
6. Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, Eisen T, et al.Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res 2009;69:6633-41.
7. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009;85:679-91.
8. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009;41:221-7.
9. Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, Jakobsdottir M, et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009;41:909-14.
10. Yang X, Yang B, Li B, Liu Y. Association between TERT-CLPTM1L rs401681[C] allele and NMSC cancer risk: a meta-Analysis including 45,184 subjects. Arch Dermatol Res 2013;305:49-52.
11. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010;42:224-8.
12. Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, et al. Seven prostate cancer susceptibility loci identified by a multistage genome-wide association study. Nat Genet 2011;43:785-91.
13. Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 2010;42:604-7.
14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
15. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y. Anovel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 2001;280:1148-54.
16. James MA, Wen W, Wang Y, Byers LA, Heymach JV, Coombes KR, et al. Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus. PLoS ONE 2012;7:e36116.
17. Baudis M. Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-Analysis of chromosomal CGH data. BMC Cancer 2007;7:226.
18. Hoglund M, Gisselsson D, Hansen GB, Mitelman F. Statistical dissection of cytogenetic patterns in lung cancer reveals multiple modes of karyotypic evolution independent of histological classification. Cancer Genet Cytogenet 2004;154:99-109.
19. Baudis M, Cleary ML. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 2001;17:1228-9.
20. Kang JU, Koo SH, Kwon KC, Park JW, Kim JM. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet 2008;182:1-11.
21. Vazquez-Mena O, Medina-Martinez I, Juarez-Torres E, Barron V, Espinosa A, Villegas-Sepulveda N, et al. Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines. PLoS ONE 2012;7:e32667.
22. Lando M, Holden M, Bergersen LC, Svendsrud DH, Stokke T, Sundfor K, et al. Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer. PLoS Genet 2009;5:e1000719.
23. Punta M, Forrest LR, Bigelow H, Kernytsky A, Liu J, Rost B. Membrane protein prediction methods. Methods 2007;41:460-74.
24. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001;305:567-80.
25. Hofmann K, Stoffel W. TMbase-A database of membrane spanning proteins segments. Biol. Chem. Hoppe-Seyler 1993;374:166.
26. von Heijne G. Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol 1992;225:487-494.
27. Das S, Bosley AD, Ye X, Chan KC, Chu I, Green JE, et al.Comparison of strong cation exchange and SDS-PAGE fractionation for analysis of multiprotein complexes. J Proteome Res 2010;9:6696-704.
28. Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, Gustafsdottir SM, et al. Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol 2002;20:473-7.
29. Takikita M, Altekruse S, Lynch CF, Goodman MT, Hernandez BY, Green M, et al. Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray. Cancer Res 2009;69:2950-5.
30. Herreros-Villanueva M, Zhang JS, Koenig A, Abel EV, Smyrk TC, Bamlet WR, et al. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis 2013;2:e61.
31. NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2014;42:D7-17.
32. Ni Z, Tao K, Chen G, Chen Q, Tang J, Luo X, et al. CLPTM1L is overexpressed in lung cancer and associated with apoptosis. PLoS ONE 2012;7:e52598.
33. Straight AF, Cheung A, Limouze J, Chen I, Westwood NJ, Sellers JR, et al. Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science 2003;299:1743-7.
34. Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, et al. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-Analysis. J Natl Cancer Inst 2012;104:840-54.
35. Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, et al. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet 2013;22:2520-8.
36. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013;45:371-84.
37. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol 2009;10:778-90.
38. Bond LM, Brandstaetter H, Sellers JR, Kendrick-Jones J, Buss F. Myosin motor proteins are involved in the final stages of the secretory pathways. Biochem Soc Trans 2011;39:1115-9.
39. Wang A, Ma X, Conti MA, Adelstein RS. Distinct and redundant roles of the non-muscle myosin II isoforms and functional domains. Biochem Soc Trans 2011;39:1131-5.
40. Mabuchi I, Okuno M. The effect of myosin antibody on the division of starfish blastomeres. J Cell Biol 1977;74:251-63.
41. De Lozanne A, Spudich JA. Disruption of the Dictyostelium myosin heavy chain gene by homologous recombination. Science 1987; 236:1086-91.
42. Urven LE, Yabe T, Pelegri F. A role for non-muscle myosin II function in furrow maturation in the early zebrafish embryo. J Cell Sci 2006; 119:4342-52.
43. Rosenblatt J, Cramer LP, Baum B, McGee KM. Myosin II-dependent cortical movement is required for centrosome separation and positioning during mitotic spindle assembly. Cell 2004;117:361-72.
44. English AR, Voeltz GK. Endoplasmic reticulum structure and interconnections with other organelles. Cold Spring Harb Perspect Biol 2013;5:a013227.
45. Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature 2010;466:68-76.
46. Sagona AP, Nezis IP, Pedersen NM, Liestol K, Poulton J, Rusten TE, et al. PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody. Nat Cell Biol 2010;12:362-71.
47. Codlin S, Haines RL, Burden JJ, Mole SE. Btn1 affects cytokinesis and cell-wall deposition by independent mechanisms, one of which is linked to dysregulation of vacuole pH. J Cell Sci 2008;121:2860-70.
48. Consortium TIBD. Isolation of a novel gene underlying Batten disease, CLN3. Cell 1995;82:949-57.